News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,525 Results
Type
Article (14958)
Company Profile (299)
Press Release (267262)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80047)
Career Advice (166)
Deals (13362)
Drug Delivery (39)
Drug Development (50724)
Employer Resources (31)
FDA (5856)
Job Trends (5190)
News (145386)
Policy (10098)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (928)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21854)
ALS (124)
Alzheimer's disease (1030)
Antibody-drug conjugate (ADC) (241)
Approvals (6051)
Artificial intelligence (259)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4583)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (104)
Brain cancer (45)
Breast cancer (343)
Cancer (3132)
Cardiovascular disease (237)
Career advice (151)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43685)
Collaboration (1148)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1101)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4321)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1403)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31693)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51778)
Executive appointments (621)
FDA (7607)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (983)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (504)
Government (1152)
Grass and pollen (3)
Guidances (168)
Healthcare (6636)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1205)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7357)
IRA (12)
Job creations (868)
Job search strategy (132)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1407)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2698)
Medtech (2707)
Mergers & acquisitions (6629)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1949)
Neurotech (1)
NextGen: Class of 2026 (2039)
Non-profit (872)
Now hiring (30)
Obesity (329)
Opinion (129)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (327)
Peanut (43)
People (26709)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15480)
Phase 2 (20288)
Phase 3 (12832)
Pipeline (3242)
Policy (91)
Postmarket research (853)
Preclinical (6538)
Press Release (30)
Prostate cancer (148)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (647)
Real estate (1457)
Recruiting (12)
Regulatory (9908)
Reports (19)
Research institute (979)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (16)
Startups (2006)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (19)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (346)
Last 30 days (1210)
Last 365 days (17823)
2026 (1655)
2025 (18118)
2024 (20580)
2023 (22460)
2022 (26902)
2021 (27874)
2020 (23412)
2019 (16328)
2018 (11822)
2017 (13804)
2016 (11908)
2015 (14401)
2014 (10424)
2013 (7513)
2012 (7568)
2011 (7656)
2010 (7450)
Location
Africa (156)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18288)
Australia (3116)
California (7087)
Canada (1837)
China (772)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39273)
Florida (902)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (396)
India (35)
Indiana (166)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5580)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1646)
New Mexico (13)
New York (1760)
North Carolina (825)
North Dakota (6)
Northern California (3484)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1277)
Puerto Rico (10)
Rhode Island (25)
South America (218)
South Carolina (9)
Southern California (2806)
Tennessee (40)
Texas (904)
United States (23348)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (594)
West Virginia (1)
Wisconsin (45)
282,525 Results for "grid therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutions
October 1, 2025
·
5 min read
Press Releases
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer
November 20, 2025
·
3 min read
Press Releases
Entero’s Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
November 14, 2025
·
2 min read
Press Releases
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
November 3, 2025
·
6 min read
Press Releases
Kneat Recognised as Leader in G2 Pharma and Biotech Fall 2025 Grid Reports
Score based on User Satisfaction and Market Presence significantly exceeds peers
September 24, 2025
·
2 min read
Press Releases
Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025
July 9, 2025
·
5 min read
Press Releases
Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities
June 11, 2025
·
2 min read
Business
Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery
Infinimmune today announced a partnership with Grid Therapeutics (“Grid”), a clinical stage biotechnology company that focuses on human-derived antibodies, to collaborate in identifying new antibody drug candidates for non-small cell lung cancer.
December 19, 2023
·
3 min read
Press Releases
Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
May 29, 2025
·
9 min read
Biotech Bay
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer.
May 22, 2024
·
5 min read
1 of 28,253
Next